Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $757,770 - $984,259
29,000 Added 20.97%
167,300 $4.82 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $654,636 - $765,204
20,400 Added 17.3%
138,300 $4.59 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $4.26 Million - $4.93 Million
117,900 New
117,900 $4.32 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $3.52 Million - $4.27 Million
-116,897 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $1.68 Million - $2.4 Million
-62,209 Reduced 34.73%
116,897 $3.62 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $6,584 - $7,472
200 Added 0.11%
179,106 $6.66 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $454,860 - $589,820
14,000 Added 8.49%
178,906 $6.43 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $499,229 - $560,520
13,500 Added 8.92%
164,906 $0
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $190,537 - $209,337
-5,081 Reduced 3.25%
151,406 $0
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1.75 Million - $1.99 Million
-45,413 Reduced 22.49%
156,487 $6.48 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $2.93 Million - $3.56 Million
-85,117 Reduced 29.66%
201,900 $0
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $1.77 Million - $1.88 Million
-53,565 Reduced 15.73%
287,017 $0
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $691,234 - $801,927
-21,662 Reduced 5.98%
340,582 $0
Q4 2017

Jan 16, 2018

BUY
$33.26 - $35.29 $4.29 Million - $4.56 Million
129,121 Added 55.39%
362,244 $0
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $64,294 - $70,827
-2,074 Reduced 0.88%
233,123 $0
Q2 2017

Aug 16, 2017

BUY
N/A
235,197
235,197 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.